Following the clinical success of new agents like nerandomilast, the next critical steps for managing ILD involve dismantling financial and geographical barriers to access, and rigorously integrating ...
EULAR—The European Alliance of Associations for Rheumatology—has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) ...
Delayed diagnosis of fibrotic ILD leads to higher mortality rates and shorter overall survival, emphasizing the need for early clinical recognition. Supplemental oxygen therapy in fibrotic ILD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback